These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29506124)

  • 1. Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
    Patel P; Yarur A; Dalal S; Sakuraba A; Rubin DT; Hanauer SB; Hanan I; Raffals LH; Cohen RD; Pekow J
    Inflamm Bowel Dis; 2018 May; 24(6):1291-1297. PubMed ID: 29506124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azathioprine without oral ciclosporin in the long-term maintenance of remission induced by intravenous ciclosporin in severe, steroid-refractory ulcerative colitis.
    Domènech E; Garcia-Planella E; Bernal I; Rosinach M; Cabré E; Fluvià L; Boix J; Gassull MA
    Aliment Pharmacol Ther; 2002 Dec; 16(12):2061-5. PubMed ID: 12452938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose oral microemulsion ciclosporin for severe, refractory ulcerative colitis.
    de Saussure P; Soravia C; Morel P; Hadengue A
    Aliment Pharmacol Ther; 2005 Aug; 22(3):203-8. PubMed ID: 16091057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: how and when to use ciclosporin in ulcerative colitis.
    Durai D; Hawthorne AB
    Aliment Pharmacol Ther; 2005 Nov; 22(10):907-16. PubMed ID: 16268964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors of response to intravenous ciclosporin in severe ulcerative colitis: the development of a novel prediction formula.
    Saito K; Katsuno T; Nakagawa T; Saito M; Sazuka S; Sato T; Matsumura T; Arai M; Miyauchi H; Matsubara H; Yokosuka O
    Aliment Pharmacol Ther; 2012 Oct; 36(8):744-54. PubMed ID: 22957944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab.
    Croft A; Walsh A; Doecke J; Cooley R; Howlett M; Radford-Smith G
    Aliment Pharmacol Ther; 2013 Aug; 38(3):294-302. PubMed ID: 23786158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.
    Hoffmann P; Wehling C; Krisam J; Pfeiffenberger J; Belling N; Gauss A
    World J Gastroenterol; 2019 Apr; 25(13):1603-1617. PubMed ID: 30983820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients.
    Protic M; Seibold F; Schoepfer A; Radojicic Z; Juillerat P; Bojic D; Mwinyi J; Mottet C; Jojic N; Beglinger C; Vavricka S; Rogler G; Frei P
    J Crohns Colitis; 2014 Nov; 8(11):1427-37. PubMed ID: 24908178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciclosporin use in acute ulcerative colitis: a long-term experience.
    Campbell S; Travis S; Jewell D
    Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):79-84. PubMed ID: 15647646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
    Chaparro M; Burgueño P; Iglesias E; Panés J; Muñoz F; Bastida G; Castro L; Jiménez C; Mendoza JL; Barreiro-de Acosta M; Senent SG; Gomollón F; Calvet X; García-Planella E; Gómez M; Hernández V; Hinojosa J; Mañosa M; Nyssen OP; Gisbert JP
    Aliment Pharmacol Ther; 2012 Jan; 35(2):275-83. PubMed ID: 22142227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe.
    Weisshof R; Ollech JE; El Jurdi K; Yvellez OV; Cohen RD; Sakuraba A; Dalal S; Pekow J; Rubin DT
    J Crohns Colitis; 2019 Sep; 13(9):1105-1110. PubMed ID: 30726894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine is essential following cyclosporine for patients with steroid-refractory ulcerative colitis.
    Miyake N; Ando T; Ishiguro K; Maeda O; Watanabe O; Hirayama Y; Maeda K; Morise K; Matsushita M; Furukawa K; Funasaka K; Nakamura M; Miyahara R; Ohmiya N; Goto H
    World J Gastroenterol; 2015 Jan; 21(1):254-61. PubMed ID: 25574099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine is safe and effective in patients with severe ulcerative colitis.
    Cheifetz AS; Stern J; Garud S; Goldstein E; Malter L; Moss AC; Present DH
    J Clin Gastroenterol; 2011 Feb; 45(2):107-12. PubMed ID: 20679905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin: a systematic literature review.
    Thorne K; Alrubaiy L; Akbari A; Samuel DG; Morrison-Rees S; Roberts SE
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):369-82. PubMed ID: 26825217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial.
    Williams JG; Alam MF; Alrubaiy L; Arnott I; Clement C; Cohen D; Gordon JN; Hawthorne AB; Hilton M; Hutchings HA; Jawhari AU; Longo M; Mansfield J; Morgan JM; Rapport F; Seagrove AC; Sebastian S; Shaw I; Travis SP; Watkins A
    Lancet Gastroenterol Hepatol; 2016 Sep; 1(1):15-24. PubMed ID: 27595142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine for the treatment of fulminant ulcerative colitis in children. Immediate response, long-term results, and impact on surgery.
    Treem WR; Cohen J; Davis PM; Justinich CJ; Hyams JS
    Dis Colon Rectum; 1995 May; 38(5):474-9. PubMed ID: 7736877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of a conservative approach in severe ulcerative colitis.
    Daperno M; Sostegni R; Scaglione N; Ercole E; Rigazio C; Rocca R; Pera A
    Dig Liver Dis; 2004 Jan; 36(1):21-8. PubMed ID: 14971812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longer term outcome of steroid refractory ulcerative colitis treated with intravenous cyclosporine without subsequent oral cyclosporine maintenance therapy.
    Rolny P; Sadik R
    Int J Colorectal Dis; 2002 Mar; 17(2):67-9. PubMed ID: 12014423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease.
    Creed TJ; Probert CS; Norman MN; Moorghen M; Shepherd NA; Hearing SD; Dayan CM;
    Aliment Pharmacol Ther; 2006 May; 23(10):1435-42. PubMed ID: 16669958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis.
    Van Assche G; D'Haens G; Noman M; Vermeire S; Hiele M; Asnong K; Arts J; D'Hoore A; Penninckx F; Rutgeerts P
    Gastroenterology; 2003 Oct; 125(4):1025-31. PubMed ID: 14517785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.